Showing 9271-9280 of 18069 results for "".
- Navigating Long-Term Obesity: Biomarker Insights and Probiotic Possibilitieshttps://reachmd.com/news/navigating-long-term-obesity-biomarker-insights-and-probiotic-possibilities/2475766/Chronic obesity presents clinicians with a series of metabolic challenges that extend beyond immediate comorbidities, potentially accelerating aging processes. Innovative strategies, including probiotic interventions, are being explored as part of a comprehensive treatment approach.
- Transformative Stroke Imaging Advances in Post-Stroke Rehabilitation and Neuroendovascular Safetyhttps://reachmd.com/news/transformative-stroke-imaging-advances-in-post-stroke-rehabilitation-and-neuroendovascular-safety/2475772/Exploring the forefront of stroke lesion mapping techniques, the latest neurological imaging advances are transforming post-stroke rehabilitation and enhancing the safety of neuroendovascular procedures. Clinicians aiming to predict gait independence after stroke co
- Pulmonary Implications of Anti-SSB/La Antibodies in Sjögren’s Diseasehttps://reachmd.com/news/pulmonary-implications-of-anti-ssbla-antibodies-in-sjogrens-disease/2475758/Understanding the pulmonary implications of autoantibodies in Sjögren’s Disease has become paramount as emerging evidence highlights a link between anti-SSB/La positivity and reduced diffusing capacity for carbon monoxide (DLCO). The challenge of identifying early l
- Rapid Genetic Shifts in SARS-CoV-2 and Their Impact on Infectious Disease Managementhttps://reachmd.com/news/rapid-genetic-shifts-in-sars-cov-2-and-their-impact-on-infectious-disease-management/2475759/Rapid genetic shifts in SARS-CoV-2 demand immediate attention from infectious disease specialists, as each new variant alters transmission dynamics, vaccine performance, and clinical decision-making. Since the Delta wave, clinicians have observed a marked divergence
- AI and Pharmaceutical Innovations in Glaucoma Carehttps://reachmd.com/news/ai-and-pharmaceutical-innovations-in-glaucoma-care/2475751/Emerging technologies are reshaping the landscape of glaucoma care; however, AI-driven detection remains underutilized at the point where early intervention could prevent irreversible vision loss. Using glaucom
- The FDA Approval of Inebilizumab for IgG4-Related Diseasehttps://reachmd.com/news/the-fda-approval-of-inebilizumab-for-igg4-related-disease/2475774/The FDA approval of Inebilizumab for IgG4-Related Disease marks a landmark in providing a targeted therapeutic option for a condition long underse
- New Genetic Insights in SCAD: Implications for Cardiology Practicehttps://reachmd.com/news/new-genetic-insights-in-scad-implications-for-cardiology-practice/2475752/In the evolving field of cardiology, new insights into genetic and familial factors are reshaping our understanding of Spontaneous Coronary Artery Dissection (SCAD), which accounts for approximately 1% to 4% of all ACS cas
- Evolving Prostate Cancer Imaging: The Impact of PSMA PET/CT and New Techniqueshttps://reachmd.com/news/evolving-prostate-cancer-imaging-the-impact-of-psma-petct-and-new-techniques/2475753/Conventional imaging fails to detect micro-metastatic disease in up to 30% of patients with biochemical recurrence, delaying targeted intervention for prostate cancer. For the practicing urologist, equivocal findings on CT and bone scans represent a diagnostic blind
- Emerging Evidence in Probiotic Use in Neonatal Intensive Carehttps://reachmd.com/news/emerging-evidence-in-probiotic-use-in-neonatal-intensive-care/2475729/Emerging evidence reveals that probiotics in neonatal intensive care not only fortify intestinal defenses against necrotizing enterocolitis but also offer a strategy to restore microbiome homeostasis when essential medications induce dys
- Revolutionizing Prostate Cancer Care with PSMA PET/CT and AI-Driven Innovationshttps://reachmd.com/news/revolutionizing-prostate-cancer-care-with-psma-petct-and-ai-driven-innovations/2475743/Revolutionizing Prostate Cancer Care with PSMA PET/CT and AI-Driven Innovations Despite challenges in achieving precision in prostate cancer management, PSMA PET/CT scanning can provide accurate localization